The goal of this study is to determine which treatment option is best to start with for patients with Severe Aplastic Anemia (SAA), between a matched unrelated donor bone marrow transplant or immune suppressive therapy, when a matched related donor is not available.

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications. This protocol will allow access to cord blood units that are unlicensed.

The purpose of this registry is to evaluate the safety and performance of a market approved surgical device. To achieve the study's purpose, our team is monitoring the health of patients during and after procedures that involve the use of this surgical device.

The purpose of this registry is to observe outcomes of heart transplant recipients who are managed with HeartCare. This is done by collecting information about your heart transplant such as test results, biopsy results, and outcomes, storing that information in a database, and using that information for research.

This study will evaluate the use of MMUD PBSC in adults and explore the safety and efficacy of MMUD BM in pediatric recipients with hematological malignancies who may lack other donor options.

The purpose of this study is to collect data from patients, caregivers, and VAD coordinators to ascertain the stressors associated with having a Ventricular Assist Device (VAD) and use that data to create support groups.

The mission of the Collaborative Islet Transplant Registry (CITR) is to expedite progress and promote safety in islet/beta cell transplantation through the collection, analysis, and communication of comprehensive and current data on all islet/beta cell transplants performed in North America, Europe and Australia.

To understand the relationship between biomarkers (found in the blood) and health outcomes among adults diagnosed with hepatocellular carcinoma who are receiving a liver transplant.